Literature DB >> 18549440

Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains.

R J F Brando1, E Miliwebsky, L Bentancor, N Deza, A Baschkier, M V Ramos, G C Fernández, R Meiss, M Rivas, M S Palermo.   

Abstract

Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 infections are considered a public health problem in both developed and developing countries because of their increasing incidence and the severity of clinical presentation. Approximately 10% of infected patients develop complications such as haemolytic uraemic syndrome (HUS) characterized by acute renal failure, thrombocytopenia and haemolytic anaemia. The precise sequence of events leading to HUS is still understood incompletely. Because of the lack of a reproducible small animal model for EHEC infections, in vivo studies examining EHEC-host early interactions are limited and insufficient. The aim of this study was to characterize the weaned BALB/c mouse as a model of E. coli O157:H7 infection. In this paper we report that human Shiga toxin 2 (Stx2)-producing EHEC strains can adhere to the intestinal epithelium of weaned BALB/c mice, and produce local damage which leads to systemic disease and death in a percentage of infected mice. The lethality of the EHEC strain is closely age-dependent, and is related to the bacterial ability to colonize intestine and to produce Stx2. It can be concluded that the weaned BALB/c mouse can be used as a small animal model to study host early responses, and the role of bacterial pathogenic factors in the induction of systemic disease, thus providing a useful tool for the evaluation of therapeutic or vaccine approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549440      PMCID: PMC2492904          DOI: 10.1111/j.1365-2249.2008.03698.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Role of the polymeric Ig receptor in mucosal B cell homeostasis.

Authors:  Tania K Uren; Finn-Eirik Johansen; Odilia L C Wijburg; Frank Koentgen; Per Brandtzaeg; Richard A Strugnell
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

2.  Evaluation of PCR and PCR-RFLP protocols for identifying Shiga toxins.

Authors:  Kim A Ziebell; Susan C Read; Roger P Johnson; Carlton L Gyles
Journal:  Res Microbiol       Date:  2002-06       Impact factor: 3.992

3.  A murine model of enterohemorrhagic Escherichia coli O157:H7 infection to assess immunopotentiating activity of drugs on mucosal immunity: effect of drugs.

Authors:  Keiji Nagano; Takeshi Sugisaki; Kazuki Taguchi; Takumi Hara; Mitsuru Naiki; Hiroshi Mori
Journal:  J Pharmacol Sci       Date:  2003-03       Impact factor: 3.337

4.  Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice.

Authors:  Keiji Nagano; Kazuki Taguchi; Takumi Hara; Shin-ichiro Yokoyama; Kenji Kawada; Hiroshi Mori
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

5.  Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response.

Authors:  Tatsuki Ohara; Seiichi Kojio; Ikue Taneike; Saori Nakagawa; Fumio Gondaira; Yukiko Tamura; Fumitake Gejyo; Hui-Min Zhang; Tatsuo Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Quorum sensing is a global regulatory mechanism in enterohemorrhagic Escherichia coli O157:H7.

Authors:  V Sperandio; A G Torres; J A Girón; J B Kaper
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.

Authors:  E Kita; Y Yunou; T Kurioka; H Harada; S Yoshikawa; K Mikasa; N Higashi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.

Authors:  M Rivas; E Miliwebsky; I Chinen; C D Roldán; L Balbi; B García; G Fiorilli; S Sosa-Estani; J Kincaid; J Rangel; P M Griffin
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

9.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 10.  Epidemiology and spectrum of disease of Escherichia coli O157.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

View more
  23 in total

1.  An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.

Authors:  Jennifer M Ritchie; Jennifer L Greenwich; Brigid M Davis; Roderick T Bronson; Dana Gebhart; Steven R Williams; David Martin; Dean Scholl; Matthew K Waldor
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 2.  Neonatal mucosal immunology.

Authors:  N Torow; B J Marsland; M W Hornef; E S Gollwitzer
Journal:  Mucosal Immunol       Date:  2016-09-21       Impact factor: 7.313

3.  Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.

Authors:  Robert L G Rojas; Priscila A D P Gomes; Leticia V Bentancor; Maria E Sbrogio-Almeida; Sérgio O P Costa; Liliana M Massis; Rita C C Ferreira; Marina S Palermo; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.

Authors:  Romina Jimena Fernandez-Brando; Gabriel Cabrera; Ariela Baschkier; María Pilar Mejías; Cecilia Analia Panek; Elizabeth Miliwebsky; María Jimena Abrey-Recalde; Leticia Verónica Bentancor; María Victoria Ramos; Marta Rivas; Marina Sandra Palermo
Journal:  Med Microbiol Immunol       Date:  2014-01-08       Impact factor: 3.402

5.  Prevention of enteric bacterial infections and modulation of gut microbiota with conjugated linoleic acids producing Lactobacillus in mice.

Authors:  Mengfei Peng; Zajeba Tabashsum; Puja Patel; Cassandra Bernhardt; Chitrine Biswas; Jianghong Meng; Debabrata Biswas
Journal:  Gut Microbes       Date:  2019-08-14

6.  Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits.

Authors:  Aruna Panda; Ivan Tatarov; Angela R Melton-Celsa; Krishnan Kolappaswamy; Edwin H Kriel; Daniel Petkov; Turhan Coksaygan; Sofie Livio; Charles G McLeod; James P Nataro; Alison D O'Brien; Louis J DeTolla
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

7.  Differential Outcome between BALB/c and C57BL/6 Mice after Escherichia coli O157:H7 Infection Is Associated with a Dissimilar Tolerance Mechanism.

Authors:  Alan M Bernal; Romina Jimena Fernández-Brando; Andrea Cecilia Bruballa; Gabriela A Fiorentino; Gonzalo Ezequiel Pineda; Elsa Zotta; Mónica Vermeulen; María Victoria Ramos; Martin Rumbo; Marina Sandra Palermo
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 8.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

9.  Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.

Authors:  María Pilar Mejias; Gabriel Cabrera; Romina Jimena Fernández-Brando; Ariela Baschkier; Giselle Ghersi; Maria Jimena Abrey-Recalde; Elizabeth Miliwebsky; Roberto Meiss; Fernando Goldbaum; Vanesa Zylberman; Marta Rivas; Marina Sandra Palermo
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

10.  Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in mice.

Authors:  Gabriel Cabrera; Romina J Fernández-Brando; María Jimena Abrey-Recalde; Ariela Baschkier; Alipio Pinto; Jorge Goldstein; Elsa Zotta; Roberto Meiss; Marta Rivas; Marina S Palermo
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.